DFTX
#1245
Definium Therapeutics, Inc. - Common Shares
43.8 2 USD
0.00%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+0.11%
Variación mensual
+4.33%
Variación en los últimos 6 meses
+161.46%
Cambio anual
+190.01%
Cierres anteriores
43.7 7
Open
43.8 2
Mínimo
43.8 2
Máximo
43.8 2
Volumen
160
Financials
- Market Capitalization 5.89 B
- Employee 106
- Founded 2010
- CEO Robert Barrow
- Website www.definiumtx.com
- Headquarter British Columbia, Canada
- FIGI BBG00F13HYQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1228 |  XENE Xenon Pharmaceuticals Inc. - Common Shares | 61.93 USD | -2.92% | +2.45% | -5.19% | +51.83% | 6.00 B USD | ||
| 1229 |  PTCT PTC Therapeutics, Inc. - Common Stock | 71.81 USD | -1.21% | +1.80% | -4.06% | +44.14% | 5.99 B USD | ||
| 1261 |  CRSP CRISPR Therapeutics AG - Common Shares | 59.37 USD | +0.24% | -0.59% | +25.20% | +12.08% | 5.74 B USD | ||
| 1272 |  LGND Ligand Pharmaceuticals Incorporated - Common Stock | 284.52 USD | -1.16% | -1.24% | -3.43% | +52.05% | 5.67 B USD |